Publication | Closed Access

Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation

Hematological MalignancyCell TherapyTransplantationOncologyMarrow TransplantationStem Cell TransplantationHematologyDli MaintenanceVenetoclax-based Salvage TherapyCell TransplantationMedicineRadiation OncologyHealth Sciences